Rheumatoid Arthritis Clinical Trial Patient Recruitment

Rheumatoid arthritis patient recruitment for biologic-naive, biologic-experienced, and treat-to-target clinical trials.

Who qualifies: Adults with moderate-to-severe RA (DAS28 ≥3.2) with inadequate response to MTX or prior biologics.

Recruitment challenges: DAS28 score requirements and prior DMARD washout periods.

Our approach: Rheumatology referral networks, RA patient registry access, and DAS28 pre-screening support.